Publikationen der ALS-Forschungsgruppe an der Charité
Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial
Maier A, Holm T, Wicks P, Steinfurth L, Linke P, Münch C,
Motor neuron diseases
Petri S, Meyer T. Motoneuronerkrankungen. Familiäre ALS, SMA, HMN Familial ALS, SMA
Heterozygous S44L missense change of the spastin gene in amyotrophic lateral sclerosis
Münch C, Rolfs A, Meyer T. Heterozygous S44L missense change of the
Elective termination of respiratory therapy in amyotrophic lateral sclerosis
Meyer T, Dullinger JS, Münch C, Keil JP, Hempel E, Rosseau S,
Thalidomide causes sinus bradycardia in ALS
Meyer T, Maier A, Borisow N, Dullinger JS, Splettstösser G, Ohlraun S,
Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis
Meyer T, Münch C, van Landeghem FK, Borisow N, Dullinger J, Linke
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis
Fernández-Santiago R, Hoenig S, Lichtner P,
Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop
Ludolph AC, Bendotti C, Blaugrund E,
Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect
Niemann S, Joos H, Meyer T,
The role of excitotoxicity in ALS – what is the evidence?
Ludolph AC, Meyer T, Riepe MW.J
Antiglutamate therapy of ALS – which is the next step?
Ludolph AC, Meyer T, Riepe MW.J
Molecular biology findings in amyotrophic lateral sclerosis
Bachus R, Claus A, Meyer T,
